Emily R. Youner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Emily R. Youner has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Alexandra Tunkel
Division of Otolaryngology-Head and Neck Surgery, The George Washington University School of Medicine & Health Sciences
1 shared publication- Alexandra Welschmeyer
Department of Otolaryngology ‐ Head and Neck Surgery University Hospitals Cleveland Medical Center Cleveland Ohio USA
1 shared publication Andrew Campbell
Comprehensive Sickle Cell Disease Program, Department of Hematology, Children’s National Hospital, Washington, DC
1 shared publicationAshkan S. Monfared
Division of Otolaryngology-Head and Neck Surgery, The George Washington University School of Medicine & Health Sciences
1 shared publicationBarbara Speller-Brown
Comprehensive Sickle Cell Disease Program, Department of Hematology, Children’s National Hospital, Washington, DC
1 shared publicationChelsea N. Cleveland
Department of Otolaryngology–Head and Neck Surgery University Hospitals Cleveland Medical Center/Case Western Reserve School of Medicine Cleveland Ohio USA
1 shared publication
Latest Publications
- Open Access
- 1 April 2026
- Published by MDPI AG in Preprints.org
Demographic Predictors of Surgical Intervention and Revision Pathways in Facial Reanimation
Background/Objectives: Facial paralysis is a debilitating condition managed with dy-namic (e.g., gracilis or temporalis transfer) and static (e.g., fascial sling) surgical inter-ventions. This study evaluates demographic factors associated with procedure selection and revision pathways. Methods: Using the TriNetX database, we identified patients with facial paralysis undergoing gracilis transfer, temporalis transfer, or fascial sling procedures. Demographics (sex, ethnicity, race) were compared across procedure types, and revision patterns were analyzed. Results: Dynamic procedures were more common among female patients (35.5% vs 23.8%, OR=1.76, 95% CI [1.47-2.11], p< 0.001). Non-Hispanic patients were less likely to undergo dynamic procedures than Hispanic patients (OR=0.36, 95% CI [0.26-0.50], p< 0.001), while non-White patients were more likely than White patients (OR=1.58, 95% CI [1.25-1.99], p< 0.001). Among patients un-dergoing initial static procedures, White patients were less likely to transition to dynamic revision compared to non-White patients (OR=0.134, 95% CI [0.07-0.228], p< 0.001). Gra-cilis transfer demonstrated the highest revision rate among procedures studied. Con-clusions: Demographic differences exist in both initial procedure selection and revision pathways for facial reanimation. These findings highlight potential disparities in surgical management and underscore the need to further investigate structural drivers of these differences.
- 1 April 2026
- Published by MDPI AG in Preprints.org
Open AccessDemographic Predictors of Surgical Intervention and Revision Pathways in Facial Reanimation
Background/Objectives: Facial paralysis is a debilitating condition managed with dy-namic (e.g., gracilis or temporalis transfer) and static (e.g., fascial sling) surgical inter-ventions. This study evaluates demographic factors associated with procedure selection and revision pathways. Methods: Using the TriNetX database, we identified patients with facial paralysis undergoing gracilis transfer, temporalis transfer, or fascial sling procedures. Demographics (sex, ethnicity, race) were compared across procedure types, and revision patterns were analyzed. Results: Dynamic procedures were more common among female patients (35.5% vs 23.8%, OR=1.76, 95% CI [1.47-2.11], p< 0.001). Non-Hispanic patients were less likely to undergo dynamic procedures than Hispanic patients (OR=0.36, 95% CI [0.26-0.50], p< 0.001), while non-White patients were more likely than White patients (OR=1.58, 95% CI [1.25-1.99], p< 0.001). Among patients un-dergoing initial static procedures, White patients were less likely to transition to dynamic revision compared to non-White patients (OR=0.134, 95% CI [0.07-0.228], p< 0.001). Gra-cilis transfer demonstrated the highest revision rate among procedures studied. Con-clusions: Demographic differences exist in both initial procedure selection and revision pathways for facial reanimation. These findings highlight potential disparities in surgical management and underscore the need to further investigate structural drivers of these differences.
- 5 November 2025
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 47 (1) , 57-63
An Analysis of Risk Factors for Sensorineural Hearing Loss in Children With Sickle Cell Disease
Objectives: The prevalence of sensorineural hearing loss (SNHL) is higher among children with sickle cell disease (SCD). This study aims to describe potential hematologic and other risk factors for SNHL in this population. Study design: Retrospective case series. Setting: Tertiary hospital. Methods: Using ICD codes for hearing loss and CPT codes for audiometry, we analyzed demographic, hematologic, treatment, and audiometric data in SCD patients at Children’s National Medical Center between 2000 and 2018. SNHL was defined as a 4-frequency bone conduction (BC) pure-tone average (PTA) ≥15 decibels. Univariate and multivariate linear regression analyses were used to study the association between changes in pure-tone average and study variables. A random intercept mixed-effects regression analysis was utilized to examine the PTA trend in patients with 3 or more audiograms. Results: We identified 201 SCD patients under 18 years old with complete audiograms. Eighty-seven percent were homozygous for hemoglobin SS, of which 21.7% had unilateral and 13.4% had bilateral sensorineural hearing loss. Tobramycin (coef: 19.76, 95% CI: 10.73-28.78, P 5 years (0.4, 95% CI: 0.1-0.8, P =0.020) and those with a history of avascular necrosis (0.6, 95% CI: 0.3-1.0, P <0.001). Conclusion: Children with SCD may be at high risk for SNHL. No single morbidity was associated with an increase in bone conduction PTA. Hydroxyurea use was associated with increased bone conduction PTA, while iron overload was associated with decreased bone conduction PTA. The etiology of SNHL in SCD is likely multifactorial. Routine audiometric studies are recommended for children with SCD, especially before and after starting new treatments.
- 5 November 2025
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 47 (1) , 57-63
An Analysis of Risk Factors for Sensorineural Hearing Loss in Children With Sickle Cell Disease
Objectives: The prevalence of sensorineural hearing loss (SNHL) is higher among children with sickle cell disease (SCD). This study aims to describe potential hematologic and other risk factors for SNHL in this population. Study design: Retrospective case series. Setting: Tertiary hospital. Methods: Using ICD codes for hearing loss and CPT codes for audiometry, we analyzed demographic, hematologic, treatment, and audiometric data in SCD patients at Children’s National Medical Center between 2000 and 2018. SNHL was defined as a 4-frequency bone conduction (BC) pure-tone average (PTA) ≥15 decibels. Univariate and multivariate linear regression analyses were used to study the association between changes in pure-tone average and study variables. A random intercept mixed-effects regression analysis was utilized to examine the PTA trend in patients with 3 or more audiograms. Results: We identified 201 SCD patients under 18 years old with complete audiograms. Eighty-seven percent were homozygous for hemoglobin SS, of which 21.7% had unilateral and 13.4% had bilateral sensorineural hearing loss. Tobramycin (coef: 19.76, 95% CI: 10.73-28.78, P 5 years (0.4, 95% CI: 0.1-0.8, P =0.020) and those with a history of avascular necrosis (0.6, 95% CI: 0.3-1.0, P <0.001). Conclusion: Children with SCD may be at high risk for SNHL. No single morbidity was associated with an increase in bone conduction PTA. Hydroxyurea use was associated with increased bone conduction PTA, while iron overload was associated with decreased bone conduction PTA. The etiology of SNHL in SCD is likely multifactorial. Routine audiometric studies are recommended for children with SCD, especially before and after starting new treatments.
- 5 January 2025
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 172 (4) , 1374-1378
Assessing the Impact of Vaccination Status on Meningitis Risk Post Cochlear Implantation
Objective: To better understand the protective benefit of pneumococcal vaccines on rates of meningitis after cochlear implantation.Study Design: Retrospective large database review.Setting: Several studies have shown that cochlear implantation increases the incidence of bacterial meningitis, mostly due to pneumococcal meningitis. However, there are no studies that have demonstrated that pneumococcal vaccination is associated with a decreased risk of meningitis among cochlear implant recipients.Methods: TriNetX, an electronic medical record database, was queried for incidence of meningitis after cochlear implantation, with and without pneumococcal vaccination.Results: There are a total of 35,434 patients in the TriNetX database who have received a cochlear implant. Of these patients, 9803 patients (27.7%) had coding sufficient to assess their immunization status and were included in our study. Of the patients in our study, 9264 patients (93.7%) had evidence of receiving a PCV immunization, while 539 (5.5%) were found to be under vaccinated. A total of 258 patients in our study had an episode of meningitis after cochlear implantation, translating to an overall rate of 2.6%. The vaccinated group demonstrated a significantly lower incidence of meningitis (2.5%, n = 236) compared to the under‐vaccinated group (4.1%, n = 22) (relative risk: 1.60; confidence interval (1.0441, 2.4586); P < .0310).Conclusion: Our study provides evidence that pneumococcal vaccination is associated with a significantly lower rate of bacterial meningitis after cochlear implantation. Meningitis is a potentially life‐threatening complication. Better adherence to pneumococcal vaccination guidelines pre‐ and post‐CI is critical to reducing the feared risk of bacterial meningitis after cochlear implantation.
- 5 January 2025
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 172 (4) , 1374-1378
Assessing the Impact of Vaccination Status on Meningitis Risk Post Cochlear Implantation
Objective: To better understand the protective benefit of pneumococcal vaccines on rates of meningitis after cochlear implantation.Study Design: Retrospective large database review.Setting: Several studies have shown that cochlear implantation increases the incidence of bacterial meningitis, mostly due to pneumococcal meningitis. However, there are no studies that have demonstrated that pneumococcal vaccination is associated with a decreased risk of meningitis among cochlear implant recipients.Methods: TriNetX, an electronic medical record database, was queried for incidence of meningitis after cochlear implantation, with and without pneumococcal vaccination.Results: There are a total of 35,434 patients in the TriNetX database who have received a cochlear implant. Of these patients, 9803 patients (27.7%) had coding sufficient to assess their immunization status and were included in our study. Of the patients in our study, 9264 patients (93.7%) had evidence of receiving a PCV immunization, while 539 (5.5%) were found to be under vaccinated. A total of 258 patients in our study had an episode of meningitis after cochlear implantation, translating to an overall rate of 2.6%. The vaccinated group demonstrated a significantly lower incidence of meningitis (2.5%, n = 236) compared to the under‐vaccinated group (4.1%, n = 22) (relative risk: 1.60; confidence interval (1.0441, 2.4586); P < .0310).Conclusion: Our study provides evidence that pneumococcal vaccination is associated with a significantly lower rate of bacterial meningitis after cochlear implantation. Meningitis is a potentially life‐threatening complication. Better adherence to pneumococcal vaccination guidelines pre‐ and post‐CI is critical to reducing the feared risk of bacterial meningitis after cochlear implantation.